UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine

Therapeutic drug monitoring, 2021-10, Vol.43 (5), p.617-623

2021

Volltextzugriff (PDF)

Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease

Frontiers in microbiology, 2023-02, Vol.14, p.1107976-1107976

2023

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment-TUMMY Study

Pharmaceutics, 2023-03, Vol.15 (3), p.972

2023

Volltextzugriff (PDF)

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency

Metabolites, 2023-10, Vol.13 (10), p.1054

2023

Volltextzugriff (PDF)

Early infliximab trough levels in paediatric IBD patients predict sustained remission

Therapeutic advances in gastroenterology, 2024-01, Vol.17, p.17562848231222337-17562848231222337

2024

Volltextzugriff (PDF)

Point-of-care therapeutic drug monitoring of tumour necrosis factor-α inhibitors using a single step immunoassay

Sensors & diagnostics, 2023-11, Vol.2 (6), p.1492-15

2023

Volltextzugriff (PDF)

Therapeutic drug monitoring of infliximab in inflammatory bowel disease patients in a teaching hospital setting: results of a prospective cohort study

European journal of gastroenterology & hepatology, 2015-03, Vol.27 (3), p.242-248

2015

Volltextzugriff (PDF)

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2015-10, Vol.149 (4), p.907-917.e7

2015

Volltextzugriff (PDF)

Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease

Clinical pharmacokinetics, 2024-04, Vol.63 (4), p.529-538

2024

Volltextzugriff (PDF)

Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease

Clinical pharmacokinetics, 2018-09, Vol.57 (9), p.1075-1106

2018

Volltextzugriff (PDF)

The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients

Inflammatory bowel diseases, 2024-09, Vol.30 (9), p.1492-1499

2024

Volltextzugriff (PDF)

The role of xanthine oxidase in thiopurine metabolism: a case report

Therapeutic drug monitoring, 2007-12, Vol.29 (6), p.845-848

2007

Volltextzugriff (PDF)

Gentamicin serum concentrations in patients with gentamicin-PMMA beads for infected hip joints: a prospective observational cohort study

Therapeutic drug monitoring, 2012-02, Vol.34 (1), p.67-71

2012

Volltextzugriff (PDF)

High systemic gentamicin levels and ototoxicity after implantation of gentamicin beads in a 70-year-old man-a case report

Acta orthopaedica, 2009-12, Vol.80 (6), p.734-736

2009

Volltextzugriff (PDF)

Pharmacokinetics of midazolam in resuscitated patients treated with moderate hypothermia

International journal of clinical pharmacy, 2013-04, Vol.35 (2), p.210-216

2013

Volltextzugriff (PDF)

Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot Study

European journal of drug metabolism and pharmacokinetics, 2023-07, Vol.48 (4), p.377-385

2023

Volltextzugriff (PDF)

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

Inflammatory bowel diseases, 2017-10, Vol.23 (10), p.1873-1881

2017

Volltextzugriff (PDF)

Patients’ beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases

European journal of gastroenterology & hepatology, 2018-02, Vol.30 (2), p.167-173

2018

Volltextzugriff (PDF)

Leflunomide Exposure and Teriflunomide Concentrations up to the Third Trimester of Pregnancy: A Case Report

Clinical drug investigation, 2022-09, Vol.42 (9), p.787-789

2022

Volltextzugriff (PDF)

6‐methylmercaptopurine‐induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients

Journal of gastroenterology and hepatology, 2017-06, Vol.32 (6), p.1183-1190

2017

Volltextzugriff (PDF)

On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients

World journal of gastroenterology : WJG, 2005-09, Vol.11 (35), p.5540

2005

Volltextzugriff (PDF)

Development of a pharmacokinetic model of mitotane: toward personalized dosing in adrenocortical carcinoma

Therapeutic drug monitoring, 2015-02, Vol.37 (1), p.58-65

2015

Volltextzugriff (PDF)

Serotonin transporter polymorphism and bleeding time during SSRI therapy

British journal of clinical pharmacology, 2008-05, Vol.65 (5), p.761-766

2008

Volltextzugriff (PDF)

6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment

European journal of gastroenterology & hepatology, 2003-01, Vol.15 (1), p.63-67

2003

Volltextzugriff (PDF)

Sa1249 Azathioprine and 6-Mercaptopurine Are Equally Effective in Thiopurine Naïve IBD Patients

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-269-S-269

2015

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(44)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(36)
Humans
(30)
Male
(22)
Female
(20)
Adult
(19)
Inflammatory Bowel Diseases - Drug Therapy
(19)
Middle Aged
(19)
Gastroenterology & Hepatology
(18)
Inflammatory Bowel Disease
(16)
Pharmacology & Pharmacy
(15)
Aged
(11)
Azathioprine - Adverse Effects
(9)
Therapeutic Drug Monitoring
(9)
Azathioprine
(8)
Biological And Medical Sciences
(8)
Immunosuppressive Agents - Adverse Effects
(8)
Medical Sciences
(8)
Patients
(8)
Pharmacokinetics
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine

Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment-TUMMY Study

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency

Early infliximab trough levels in paediatric IBD patients predict sustained remission

Point-of-care therapeutic drug monitoring of tumour necrosis factor-α inhibitors using a single step immunoassay

Therapeutic drug monitoring of infliximab in inflammatory bowel disease patients in a teaching hospital setting: results of a prospective cohort study

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease

Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease

The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients

The role of xanthine oxidase in thiopurine metabolism: a case report

Gentamicin serum concentrations in patients with gentamicin-PMMA beads for infected hip joints: a prospective observational cohort study

High systemic gentamicin levels and ototoxicity after implantation of gentamicin beads in a 70-year-old man-a case report

Pharmacokinetics of midazolam in resuscitated patients treated with moderate hypothermia

Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot Study

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

Patients’ beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases

Leflunomide Exposure and Teriflunomide Concentrations up to the Third Trimester of Pregnancy: A Case Report

6‐methylmercaptopurine‐induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients

On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients

Development of a pharmacokinetic model of mitotane: toward personalized dosing in adrenocortical carcinoma

Serotonin transporter polymorphism and bleeding time during SSRI therapy

6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment

Sa1249 Azathioprine and 6-Mercaptopurine Are Equally Effective in Thiopurine Naïve IBD Patients

Suchergebnisse filtern